Lv51
1400 积分 2022-09-22 加入
Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study
26分钟前
已完结
Phase 1b/2a randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with chronic hepatitis B
27分钟前
已完结
Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated BBB opening: A novel combinatorial immunotherapy regimen for gliomas
9天前
已完结
The study of immune checkpoint inhibitors in chronic hepatitis B virus infection
19天前
已完结
DC vaccine enhances CAR-T cell antitumor activity by overcoming T cell exhaustion and promoting T cell infiltration in solid tumors
28天前
已完结
Jiawei Yanghe Decoction suppresses breast cancer by regulating immune responses via JAK2/STAT3 signaling pathway
1个月前
已完结
Fc-silent anti-TIGIT antibodies potentiate anti-tumor immunity without depleting regulatory T cells
1个月前
已完结
Fcγ receptors and immunomodulatory antibodies in cancer
1个月前
已完结
Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials
2个月前
已完结
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
2个月前
已完结
皖公网安备34019202002308
